An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease. Dunn B, Stein P, Temple R, Cavazzoni P, et al. N Engl J Med 2021 Jul 28. doi: 10.1056/NEJMc2111960.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dunn B, Stein P, Temple R, Cavazzoni P, et al. An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease. N Engl J Med 2021 Jul 28. doi: 10.1056/NEJMc2111960.
PMID: 34320283